Adjunctive Short‐Wave Diathermy to High‐Frequency Chest Wall Oscillation for Acute Exacerbation of COPD: A Randomized Controlled Trial
Canadian Respiratory Journal · 2026
DOI: 10.1155/carj/6813132 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Canadian Respiratory Journal, 2026. Verfasst von Qinqin Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Yongkang First People's Hospital, Jinhua, Zhejiang, China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Diathermy, Chest Wall Oscillation, Short-Wave Therapy. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: COPD
Abstract (Originalsprache)
Objective
This study aimed to evaluate the efficacy and safety of combining short‐wave diathermy (SWD) with high‐frequency chest wall oscillation (HFCWO) compared with HFCWO alone and routine treatment in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
Methods
This single‐center, parallel‐group randomized controlled trial enrolled 89 patients with AECOPD admitted to Yongkang First People’s Hospital between March 2024 and March 2025. Participants were randomly assigned (1:1:1) to receive routine treatment alone (control group), routine treatment plus HFCWO (HFCWO group), or routine treatment plus combined SWD and HFCWO (combined group) for 72 h. Primary and secondary outcomes were assessed at baseline and after 72 h of intervention, with both within‐group and between‐group comparisons performed. Primary outcomes included changes in the COPD Assessment Test (CAT) and Breathlessness, Cough, and Sputum Scale (BCSS) scores. Secondary outcomes included lung function parameters (FEV 1 , FVC, and FEV 1 /FVC), arterial blood gas parameters (PaO 2 and PaCO 2 ), inflammatory markers (interleukin‐6, C‐reactive protein, and white blood cell count), and quantitative sputum indices (24‐h sputum volume, total cell count, and differential counts).
Results
After the 72‐h intervention, the combined therapy group demonstrated significantly greater reductions in CAT and BCSS scores compared with both the HFCWO group and the control group ( p < 0.05). Combined therapy also achieved superior improvements in arterial blood gas parameters (PaO 2 and PaCO 2 ) and sputum clearance indices (24‐h sputum volume and neutrophil and eosinophil percentages) compared with HFCWO alone or routine treatment. In contrast, no significant differences were observed in lung function parameters (FEV 1 and FVC) or inflammatory markers (IL‐6, CRP, and WBC).
Conclusions
The combined intervention significantly improves respiratory symptoms, arterial oxygenation, and sputum clearance in patients with AECOPD compared with HFCWO alone or routine treatment. The addition of thermal therapy enhances the clinical efficacy of mechanical airway clearance, offering a feasible adjunctive strategy for acute‐phase management of AECOPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yongkang First People's Hospital, Jinhua, Zhejiang, China.
ORCID-Profile: Qinqin Li, Jielu Sun, Lujing Ying, Zaishuang Ying
Zitieren
APA
Li, Q., Sun, J., Ying, L., & Ying, Z. (2026). Adjunctive Short‐Wave Diathermy to High‐Frequency Chest Wall Oscillation for Acute Exacerbation of COPD: A Randomized Controlled Trial. Canadian Respiratory Journal. https://doi.org/10.1155/carj/6813132
Vancouver
Li Q, Sun J, Ying L, Ying Z. Adjunctive Short‐Wave Diathermy to High‐Frequency Chest Wall Oscillation for Acute Exacerbation of COPD: A Randomized Controlled Trial. Canadian Respiratory Journal. 2026. doi:10.1155/carj/6813132
BibTeX
@article{Li2026,
author = {Li, Qinqin and Sun, Jielu and Ying, Lujing and Ying, Zaishuang},
title = {Adjunctive Short‐Wave Diathermy to High‐Frequency Chest Wall Oscillation for Acute Exacerbation of COPD: A Randomized Controlled Trial},
journal = {Canadian Respiratory Journal},
year = {2026},
doi = {10.1155/carj/6813132}
}
EUVIMED